CS DIAGNOSTICS CORP. (CSDX)
Headquartered in Neuss, Germany, CS Diagnostics Corp. was established in 1996. The company is dedicated to the development, production, and worldwide distribution of a range of health and medical-grade products, catering to both domestic German and international markets. Among its key offerings are MEDUSA, an exclusive surface disinfectant, and CS-Protect Hydrogel, a specialized tissue-spacing gel for radiation therapy applications. The firm rebranded as CS Diagnostics Corp. in August 2023, having previously operated under the name FlashZero Corp.
Sector: Specialty Cleaning, Polishing and Sanitation Preparations
Industry: Medical - Devices
CS Diagnostics Corp.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 137.34M shares outstanding
Headquartered in Neuss, Germany, CS Diagnostics Corp. was established in 1996.
The company is dedicated to the development, production, and worldwide distribution of a range of health and medical-grade products, catering to both domestic German and international markets. Among its key offerings are MEDUSA, an exclusive surface disinfectant, and CS-Protect Hydrogel, a specialized tissue-spacing gel for radiation therapy applications.
The firm rebranded as CS Diagnostics Corp. in August 2023, having previously operated under the name FlashZero Corp.
Leadership
Janel Luzana
Corporate Secretary
Mohammad EsSayed
VP, CFO & Director
Sabrina Kummer Godehardt
Director of Business Development & Director
Thomas Fahrhoefer
President, Chairman & CEO
Employees
1
Country
DE
Sector
Healthcare
Website
csdcorp.us
| Name | Shares | % | Source |
|---|---|---|---|
CS Diagnostics Pharma GmbH 10% Owner | 104.5M | 76.1% | FORM 4 |
CS Interpharm LLC 10% Owner | 49.4M | 35.9% | FORM 4 |
CS Interpharm General Trading Co. LLC 10% Owner | 42.6M | 31.0% | FORM 4 |
Insiders
- CS Diagnostics Pharma GmbH10% Owner
- CS Interpharm LLC10% Owner
- CS Interpharm General Trading Co. LLC10% Owner
based on 137.34M shares outstanding
30d Avg
11.21K
60d Avg
28.82K
90d Avg
21.55K